Pediatric immunization-related safety incidents in primary care: A mixed methods analysis of a national database

Philippa Rees1, Adrian Edwards1, Colin Powell1

  • 1Primary Care Patient Safety (PISA) Research Group, Division of Population Medicine, Cardiff University, Neuadd Meirionnydd, Heath Park, Cardiff CF14 4YS, UK.

Vaccine
|July 1, 2015
PubMed

Insights

Pediatric immunization errors in England and Wales led to harm in over 60% of reported incidents, including three deaths. Improving data systems and parent involvement can enhance vaccine safety for children.

Area of Science:

  • Pediatric patient safety
  • Immunization practices
  • Healthcare quality improvement

Background:

  • Millions of vaccine doses are administered annually to children in England and Wales.
  • Immunization errors pose a risk to patient safety and public health.
  • A national reporting system was used to analyze pediatric immunization safety incidents.

Purpose of the Study:

  • To characterize pediatric immunization-related safety incident reports from primary care in England and Wales (2002-2013).
  • To identify incident types, contributing factors, harm severity, and outcomes.
  • To inform strategies for mitigating future immunization safety incidents.

Main Methods:

  • A cross-sectional mixed methods study design.
  • Analysis of free-text incident reports from a national reporting system.
  • Coding of incident type, contributory factors, harm, and outcomes, followed by thematic analysis.

Main Results:

  • 1745 reports were identified, with 61.7% describing harm.
  • Harm outcomes included three deaths, 67 moderate harm, and 1007 low harm reports.
  • Common administration errors involved wrong dose (27.3%), timing (16.8%), and vaccine (14.3%); documentation failures were frequent.

Conclusions:

  • This study represents the largest examination of contributory factors for pediatric immunization safety incidents.
  • Recommendations include investment in IT infrastructure for data linkage and risk prediction.
  • Developing parent-involved consultation models and adopting best practices are crucial for improving vaccine safety, especially for vulnerable children.
Abstract

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
83
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
380
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
486
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
776
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
824
Vaccinations01:51

Vaccinations

Overview
54.1K